Because as we saw when Cadbury’s – that great Birmingham company – was bought by Kraft, or when AstraZeneca was almost sold to Pfizer, transient shareholders – who are mostly companies investing other people’s money – are not the only people with an interest when firms are sold or close. Workers have a stake, local communities have a stake, and often the whole country has a stake. It is hard to think of an industry of greater strategic importance to Britain than its pharmaceutical industry, and AstraZeneca is one of the jewels in its crown. Yet two years ago the Government almost allowed AstraZeneca to be sold to Pfizer, the US company with a track record of asset stripping and whose self-confessed attraction to the deal was to avoid tax. A proper industrial strategy wouldn’t automatically stop the sale of British firms to foreign ones, but it should be capable of stepping in to defend a sector that is as important as pharmaceuticals is to Britain.
Mrs May”s official spokeswoman said the swoop by the Japanese firm for one of the UK”s biggest technology companies “was a clear vote of confidence in Britain” and showed the UK could make a success of leaving the EU.
Mrs May gave her support to the deal after a conversation with SoftBank”s chief Masayoshi Son on Sunday, where she learned of the Japanese firm”s intent to double ARM”s UK workforce and keep its headquarters in Cambridge.
it was said before the vote that Brexit would cost us an arm and a leg, there goes the ARM...